WallStreetZenWallStreetZen

How to Buy Cytosorbents Stock

Cytosorbents Corp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology.

Cytosorbents stock last closed at $0.74, down 18.05% from the previous day, and has decreased 47.89% in one year. It has underperformed other stocks in the Medical Devices industry by 0.71 percentage points. Cytosorbents stock is currently +5.71% from its 52-week low of $0.70, and -65.58% from its 52-week high of $2.15.

There are currently 54.43M CTSO shares outstanding. The market capitalization of CTSO is $40.28M. In the last 24 hours, 515,639 CTSO shares were traded.

How to Buy Cytosorbents Stock

Wondering how to invest in Cytosorbents stock? Here's how.
  1. Figure out where to buy Cytosorbents stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Cytosorbents stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Choose your payment method and add your details.
  4. Analyze Cytosorbents stock: The Cytosorbents ticker symbol is CTSO. Is Cytosorbents stock a good investment? Should you buy shares of CTSO? How do CTSO's underlying business fundamentals look? Do top analysts think Cytosorbents is a good buy? Why has CTSO's stock price moved recently? (Hint: Our stock market research website can help you understand if CTSO is a good stock to buy).
  5. Place your CTSO buy order: Decide if you will purchase CTSO shares at the current market price or use a limit order to buy CTSO shares at a particular price.
  6. Monitor your CTSO investment: Create a watchlist to watch your new investment in Cytosorbents shares.

Step 1: Figure out where to buy Cytosorbents stock

You need a brokerage account to access the NASDAQ market and buy CTSO shares.

A brokerage account enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen the best brokerage, you'll need to fill out some personal information so you are able to invest in CTSO stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open a new trading account.
  1. Submit your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your brokerage account

Now that you have finished signing up on the stock trading app, your next step is to transfer the money for your investment:

Check out the walkthrough below to see the process of depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Cytosorbents stock

After you have figured out the best place to buy Cytosorbents stock, it's absolutely critical to evaluate their stock prior to buying, so you truly understand the risk as well as the opportunity.

Cytosorbents Metrics

CTSO Price
$0.74
1w %
-26%
1y %
-47.89%
5y %
-83.95%
P/E
-1.4x
P/B
2.41x
P/S
1.08x
PEG
N/A
Revenue
$37.16M
Earnings
-$25.53M
Fore. Rev. Growth
12.57%
Fore. Earn. Growth
N/A
Market Cap
$40.28M
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of CTSO

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CTSO's stock page.

What is the fair value of CTSO stock?

You can use many financial metrics, analyses, models, and charts to gauge CTSO's fair value.

Using relative valuations methods:

  • CTSO may be undervalued based on its P/B ratio of 2.41x, relative to Medical Devices industry P/B ratio of 4.04x

You can access additional valuation analysis on CTSO's stock here.

Is CTSO a healthy company?

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the CTSO balance sheet.

Negative Health Checks:

  • There are more long-term liabilities than short-term assets on the CTSO balance sheet.
  • Total CTSO debt is higher than 5 years ago, relative to shareholder equity.
  • CTSO has a relatively high debt to equity ratio of 2.19.
  • CTSO has cash burn of 21539366. It does not have sufficient cash and short-term investments to cover this.
  • CTSO profit margin has gone up by 0.04 percentage points in the past year, but the company is still unprofitable.
  • CTSO has $14.94M in cash and short term investments. This is not sufficient to cover its annual cash burn of $21.54M.

Is it a good time to buy CTSO stock, according to Wall Street analysts?

Out of 3 Wall Street analysts who give ratings on CTSO, the consensus analyst rating on Cytosorbents is a Strong Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Cytosorbents stock forecast page.

CTSO Momentum

SMA10
0.93
SMA20
1.01
SMA50
1.13
SMA100
1.06
SMA200
0.99
MACD
-0.08
MACD Signal
-0.06
MACD Histogram
-0.02
RSI
24.69
Stochastic %K
16.91
Stochastic %D
13.26
StochRSI %K
35.5
StochRSI %D
29.57

CTSO Growth Metrics

Last year, CTSO revenue was $37.16M. During the last 5 year, CTSO's revenue has grown by 9.83% per year. This was slower than the Medical Devices industry average of 11%.

Dig into CTSO's earnings and revenue performance here.

What are CTSO executives and large shareholders up to?

Over the last year, insiders at CTSO have bought more shares than they have sold.

Michael G. Bator, Director of CTSO, was the latest CTSO insider to buy. They bought $50,000.02 worth of CTSO shares on Dec 13, 2023.

Get more info about who owns CTSO stock here.

Does CTSO provide a stable income stream?

No, Cytosorbents doesn't provide an income stream by paying out dividends.

What others are saying about CTSO

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your CTSO buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are generally the best for newer investors.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a given price limit, place a limit order.

Press the Open button and eToro will place the order.

If you need additional help investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Monitor your CTSO investment

Now that you own some shares in CTSO, you'll want to stay up-to-date on your stock purchase.

Start a watchlist to monitor your CTSO stock.

CTSO Feed

How to Buy Stock in Cytosorbents

To reiterate, here are the 6 steps to buy stock in Cytosorbents:

  1. Figure out where to buy Cytosorbents stock
  2. Create a brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Cytosorbents stock
  5. Place your CTSO buy order
  6. Monitor your CTSO investment

If you need a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to track your investment in Cytosorbents, add CTSO to your watchlist by clicking the button below.

NASDAQ: CTSO
$0.74-0.16 (-18.05%)
Updated Nov 8, 2024
Open eToro Account
NASDAQ: CTSO
$0.74-0.16 (-18.05%)
Updated Nov 8, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cytosorbents share?

As of Nov 8, 2024, it costs $0.74 to buy one share of Cytosorbents stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.37, you can buy 0.5 shares of CTSO.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cytosorbents stock?

According to 3 Wall Street analysts who monitor Cytosorbents, their consensus recommendation is to buy Cytosorbents stock.

What is the best way to buy Cytosorbents stock?

One way to place an order for Cytosorbents stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.